Sandoz Group AG Stock
Sandoz Group AG dominated the market today, gaining €3.56 (4.850%).
Pros and Cons of Sandoz Group AG in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
News
Sandoz delivers strong H1 2026 results, with outstanding biosimilar growth in the second quarter
Sandoz delivers strong H1 2026 results, with outstanding biosimilar growth in the second quarter
Sandoz takes further steps to resolve legacy US generic medicine litigation
Sandoz takes further steps to resolve legacy US generic medicine litigation
Sandoz confirms regulatory approval for new semaglutide treatment option in Brazil, paving way to expand patient access
Sandoz confirms regulatory approval for new semaglutide treatment option in Brazil, paving way to expand patient access